KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Total Current Liabilities (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Total Current Liabilities for 17 consecutive years, with $517.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 10.52% to $517.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $517.0 million, a 10.52% increase, with the full-year FY2025 number at $517.0 million, up 10.52% from a year prior.
  • Total Current Liabilities was $517.0 million for Q4 2025 at Bio-Rad Laboratories, down from $522.3 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $680.9 million in Q4 2021 to a low of $466.2 million in Q1 2024.
  • A 5-year average of $558.6 million and a median of $558.2 million in 2023 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: tumbled 36.66% in 2021, then grew 12.72% in 2025.
  • Bio-Rad Laboratories' Total Current Liabilities stood at $680.9 million in 2021, then dropped by 16.48% to $568.7 million in 2022, then dropped by 8.07% to $522.8 million in 2023, then dropped by 10.52% to $467.8 million in 2024, then grew by 10.52% to $517.0 million in 2025.
  • Per Business Quant, the three most recent readings for BIO's Total Current Liabilities are $517.0 million (Q4 2025), $522.3 million (Q3 2025), and $548.9 million (Q2 2025).